Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clostridium difficile (C. diff)
Research
mRNA vaccine protects mice from deadly C. diff infections
The vaccine could become a tool to target different strains of C. diff and prevent the pesky bacteria from trapping patients in a cycle of disease.
Darren Incorvaia
Oct 4, 2024 1:08pm
Crestone’s antibiotic beats vancomycin at treating C. diff
Sep 5, 2024 3:11pm
Chasing Seres, Vedanta bags $107M to run phase 3 C. diff trial
Apr 25, 2023 9:40am
Ferring's research site closure signals shift from internal R&D
Apr 11, 2023 11:22am
Destiny seals C. diff therapy's phase 3 fate with Sebela
Feb 24, 2023 10:10am
FDA committee votes for Ferring's C. difficile therapy
Sep 23, 2022 10:15am
